227 related articles for article (PubMed ID: 2901907)
21. Purine metabolism in myeloid precursor cells during maturation. Studies with the HL-60 cell line.
Lucas DL; Webster HK; Wright DG
J Clin Invest; 1983 Dec; 72(6):1889-900. PubMed ID: 6139386
[TBL] [Abstract][Full Text] [Related]
22. Induction of erythroid differentiation and modulation of gene expression by tiazofurin in K-562 leukemia cells.
Olah E; Natsumeda Y; Ikegami T; Kote Z; Horanyi M; Szelenyi J; Paulik E; Kremmer T; Hollan SR; Sugar J
Proc Natl Acad Sci U S A; 1988 Sep; 85(17):6533-7. PubMed ID: 2901100
[TBL] [Abstract][Full Text] [Related]
23. Expression of the transforming growth factor alpha protooncogene in differentiating human promyelocytic leukemia (HL-60) cells.
Walz TM; Malm C; Wasteson A
Cancer Res; 1993 Jan; 53(1):191-6. PubMed ID: 7677980
[TBL] [Abstract][Full Text] [Related]
24. Altered regulation of c-myc in an HL-60 differentiation resistant subclone, HL-60-1E3.
Ely CM; Leftwich JA; Chenevix-Trench G; Hall RE; Westin EH
Cancer Res; 1987 Sep; 47(17):4595-600. PubMed ID: 3476196
[TBL] [Abstract][Full Text] [Related]
25. c-myc and c-myb oncoproteins during induced maturation of myeloid and erythroid human leukemic cell lines.
Pedrazzoli P; Bains MA; Watson R; Fisher J; Hoy TG; Jacobs A
Cancer Res; 1989 Dec; 49(24 Pt 1):6911-6. PubMed ID: 2684403
[TBL] [Abstract][Full Text] [Related]
26. Induction of the differentiation of synchronized HL-60 leukemia cells by tiazofurin.
Sokoloski JA; Blair OC; Carbone R; Sartorelli AC
Exp Cell Res; 1989 May; 182(1):234-41. PubMed ID: 2714402
[TBL] [Abstract][Full Text] [Related]
27. Effects of the IMP-dehydrogenase inhibitor, Tiazofurin, in bcr-abl positive acute myelogenous leukemia. Part II. In vitro studies.
Wright DG; Boosalis M; Malek K; Waraska K
Leuk Res; 2004 Nov; 28(11):1137-43. PubMed ID: 15380336
[TBL] [Abstract][Full Text] [Related]
28. [Low-dose recombinant human tumor necrosis-alpha in HL-60 leukemic cell line: effect on induced differentiation and regulating expression of c-myc, c-fos proto-oncogenes].
Yuan YC; Shen SY
Zhonghua Yi Xue Za Zhi; 1994 Nov; 74(11):666-9, 708-9. PubMed ID: 7866900
[TBL] [Abstract][Full Text] [Related]
29. DMSO-like rapid decrease in c-myc and c-myb mRNA levels and induction of differentiation in HL-60 cells by the anthracycline antitumor antibiotic aclarubicin.
Stöcker U; Schaefer A; Marquardt H
Leukemia; 1995 Jan; 9(1):146-54. PubMed ID: 7845009
[TBL] [Abstract][Full Text] [Related]
30. Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
Franchetti P; Cappellacci L; Grifantini M; Barzi A; Nocentini G; Yang H; O'Connor A; Jayaram HN; Carrell C; Goldstein BM
J Med Chem; 1995 Sep; 38(19):3829-37. PubMed ID: 7562914
[TBL] [Abstract][Full Text] [Related]
31. Modulation of IMP dehydrogenase activity and guanylate metabolism by tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide).
Lui MS; Faderan MA; Liepnieks JJ; Natsumeda Y; Olah E; Jayaram HN; Weber G
J Biol Chem; 1984 Apr; 259(8):5078-82. PubMed ID: 6143752
[TBL] [Abstract][Full Text] [Related]
32. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
Gogusev J; Barbey S; Nezelof C
Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
[TBL] [Abstract][Full Text] [Related]
33. Studies on the mechanism of action of tiazofurin metabolism to an analog of NAD with potent IMP dehydrogenase-inhibitory activity.
Cooney DA; Jayaram HN; Glazer RI; Kelley JA; Marquez VE; Gebeyehu G; Van Cott AC; Zwelling LA; Johns DG
Adv Enzyme Regul; 1983; 21():271-303. PubMed ID: 6152729
[TBL] [Abstract][Full Text] [Related]
34. Protooncogene expression in normal, preleukemic, and leukemic murine erythroid cells and its relationship to differentiation and proliferation.
Robert-Lézénès J; Meneceur P; Ray D; Moreau-Gachelin F
Cancer Res; 1988 Jul; 48(14):3972-6. PubMed ID: 3164254
[TBL] [Abstract][Full Text] [Related]
35. Synergistic growth inhibitory and differentiating effects of trimidox and tiazofurin in human promyelocytic leukemia HL-60 cells.
Szekeres T; Fritzer M; Strobl H; Gharehbaghi K; Findenig G; Elford HL; Lhotka C; Schoen HJ; Jayaram HN
Blood; 1994 Dec; 84(12):4316-21. PubMed ID: 7994048
[TBL] [Abstract][Full Text] [Related]
36. Effects of interferon-gamma on proto-oncogene expression during induction of human monocytic differentiation.
Sariban E; Mitchell T; Griffin J; Kufe DW
J Immunol; 1987 Mar; 138(6):1954-8. PubMed ID: 3102606
[TBL] [Abstract][Full Text] [Related]
37. Cell differentiation and altered IMP dehydrogenase expression induced in human T-lymphoblastoid leukemia cells by mycophenolic acid and tiazofurin.
Kiguchi K; Collart FR; Henning-Chubb C; Huberman E
Exp Cell Res; 1990 Mar; 187(1):47-53. PubMed ID: 1967583
[TBL] [Abstract][Full Text] [Related]
38. Altered expression of cell cycle related genes including c-myb in a subclone of HL-60 that exhibits reversible differentiation.
Boise LH; Grant S; Westin EH
Cell Growth Differ; 1992 Jan; 3(1):53-61. PubMed ID: 1318070
[TBL] [Abstract][Full Text] [Related]
39. Tiazofurin decreases Ras-GTP complex in K562 cells.
Hata Y; Natsumeda Y; Weber G
Oncol Res; 1993; 5(4-5):161-4. PubMed ID: 8305741
[TBL] [Abstract][Full Text] [Related]
40. Differentiation of human prostate cancer PC-3 cells induced by inhibitors of inosine 5'-monophosphate dehydrogenase.
Floryk D; Tollaksen SL; Giometti CS; Huberman E
Cancer Res; 2004 Dec; 64(24):9049-56. PubMed ID: 15604271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
